axatilimab-csfr | B761411 | INCYTE CORP
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Aug. 14, 2036 | Active | Computed |
| 7-Year Orphan | Aug. 14, 1931 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12403181(method of use) · relevance 72/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
10 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.